Cargando…

Parkinson’s Disease: We Care!

Detalles Bibliográficos
Autores principales:	Bloem, Bastiaan R., Brundin, Patrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592664/ https://www.ncbi.nlm.nih.gov/pubmed/32741843 http://dx.doi.org/10.3233/JPD-209003

Ejemplares similares

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

The Journal of Parkinson’s Disease Takes the Open Road
por: Bloem, Bastiaan R., et al.
Publicado: (2023)

Addressing the “Replication Crisis” in the Field of Parkinson’s Disease
por: Albanese, Federica, et al.
Publicado: (2023)

Parkinson Matters
por: Darweesh, Sirwan K.L., et al.
Publicado: (2018)

COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
por: Bloem, Bastiaan R., et al.
Publicado: (2021)

Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease
por: Darweesh, Sirwan K.L., et al.
Publicado: (2022)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Biphasic Levodopa-Induced Freezing of Gait in Parkinson’s Disease
por: Nonnekes, Jorik, et al.
Publicado: (2020)

Personalizing decision-making for persons with Parkinson’s disease: where do we stand and what to improve?
por: van den Heuvel, Lieneke, et al.
Publicado: (2022)

Personalized Care Management for Persons with Parkinson’s Disease
por: van Halteren, Angelika D., et al.
Publicado: (2020)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Recent advances in the assessment and treatment of falls in Parkinson's disease
por: Snijders, Anke H, et al.
Publicado: (2010)

The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities
por: Helmich, Rick C., et al.
Publicado: (2020)

Prospective assessment of subjective sleep benefit in Parkinson’s disease
por: van Gilst, Merel M, et al.
Publicado: (2015)

Top Altmetric Scores in the Parkinson’s Disease Literature
por: Araújo, Rui, et al.
Publicado: (2017)

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017)

Music to move persons with Parkinson’s disease: a personalized approach
por: Holter, Susanne Ten, et al.
Publicado: (2021)

Mask on, Mask off: Subclinical Parkinson’s Disease Unveiled by COVID-19
por: Beckers, Milan, et al.
Publicado: (2023)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
por: Noordegraaf, Marina A., et al.
Publicado: (2023)

Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease
por: Smulders, Katrijn, et al.
Publicado: (2014)

Personalized care management for persons with Parkinson's disease: A telenursing solution
por: Mancini, Francesca, et al.
Publicado: (2020)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical Practice
por: Tosserams, Anouk, et al.
Publicado: (2022)

What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
por: Dunning, Christopher J.R., et al.
Publicado: (2013)

The silver linings of Parkinson’s disease
por: Alonso-Canovas, Araceli, et al.
Publicado: (2022)

Recognition of physiotherapists’ expertise in Parkinson’s disease
por: Ketelaar, Nicole ABM, et al.
Publicado: (2013)

The state of telemedicine for persons with Parkinson's disease
por: van den Bergh, Robin, et al.
Publicado: (2021)

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson’s disease etiology
por: Coetzee, Simon G., et al.
Publicado: (2016)

Narrative medicine pinpoints loss of autonomy and stigma in Parkinson’s disease
por: Florijn, Barend W., et al.
Publicado: (2023)

Management of Parkinson’s Disease 20 Years from Now: Towards Digital Health Pathways
por: Klucken, Jochen, et al.
Publicado: (2018)

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
por: Kulkarni, Aishwarya S, et al.
Publicado: (2022)

Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson’s disease
por: Louter, Maartje, et al.
Publicado: (2014)

Dementia and Parkinson's Disease: Similar and Divergent Challenges in Providing Palliative Care
por: van der Steen, Jenny T., et al.
Publicado: (2019)

Recognition and diagnosis of sleep disorders in Parkinson’s disease
por: Louter, Maartje, et al.
Publicado: (2012)

Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study
por: van der Eijk, Martijn, et al.
Publicado: (2015)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jcodu8ogcvhsr185831itdtm4t